Cost of Goods Sold (Quarterly)

Cost of Goods Sold: The difference between beginning and ending inventories for tangible products, resulting in an expense that reflects production and sales costs.

Zimmer Biomet Holdings, Inc. (ZBH) had Cost of Goods Sold of $576.20M for the most recently reported fiscal quarter, ending 2026-03-31.

Quarterly Annual

Figures for fiscal quarter ending 2026-03-31

Income Statement Financials
Revenue	$2.09B
Net Income	$238.10M
Cost of Goods Sold	$576.20M
Gross Profit	$1.51B
Operating Expenses	$1.71B
Operating Income	$373.20M
Non-Operating Income/Expense	$-71.80M
Pre-Tax Income	$301.30M
Normalized Pre-Tax Income	$301.30M
Income after Taxes	$238.30M
Income from Continuous Operations	$238.30M
Consolidated Net Income/Loss	$238.30M
Normalized Income after Taxes	$238.30M
EBIT	$373.20M
EBITDA	$643.20M
Weighted-Average Shares Outstanding (Basic)	195.00M
Weighted-Average Shares Outstanding (Diluted)	195.80M
Earnings per Share (EPS) (Basic)	$1.22
Earnings per Share (EPS) (Diluted)	$1.22
Balance Sheet Financials
Current Assets	$4.96B
Property, Plant, and Equipment	$2.21B
Long-Term Assets	$17.76B
Total Assets	$22.72B
Current Liabilities	$2.86B
Long-Term Debt	$6.30B
Long-Term Liabilities	$7.18B
Total Liabilities	$10.04B
Common Equity	$12.68B
Tangible Shareholders Equity	$-1.80B
Shareholders Equity	$12.68B
Common Shares Outstanding	193.40M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$359.40M
Cash Flow from Investing Activities	$-159.00M
Cash Flow from Financial Activities	$-369.20M
Beginning Cash	$591.90M
End Cash	$424.20M
Increase/Decrease in Cash	$-167.70M
Stock-Based Compensation	$24.20M
Common Stock Dividends Paid	$-46.90M
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.73
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.33
Debt to Equity Ratio	0.59
Gross Margin	72.39%
Operating Margin	17.88%
EBIT Margin	17.88%
EBITDA Margin	--
Pre-Tax Profit Margin	14.44%
Profit Margin	11.41%
Free Cash Flow	$245.90M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.09
Inventory Turnover	0.26
Receiveable Turnover	1.21
Days Sales in Receivables	74.56
Return on Equity	1.88%
Return on Tangible Equity	-13.26%
Return on Assets	1.05%
Return on Investments	1.26%
Book Value Per Share	$65.57
Free Cash Flow per Share	$1.26
Operating Cash Flow per Share	$1.84

Data from Zacks Investment Research, Inc.